Vaccination Policy: It is a health policy that the government adopts for the process of vaccination. Vaccination policies have been developed over the approximately two centuries since the invention of vaccinations with the motive of suppress disease from, or boost a strong immunity system for, the population the government wants to protect. When EPI was established over 40 years ago, its main focus was on vaccinating infants with a limited number of traditional vaccines. Today the vaccine world has changed completely When EPI was established over 40 years ago, its focus was on vaccinating infants with a limited number of traditional vaccines. Today the vaccine world has changed dramatically.
Regulatory Affairs: Although the European Medicines Agency (EMA) and the World Health Organization (WHO) and the United States Food and Drug Administration (USFDA), already must established a Regulatory framework for the guideline for vaccines, the other region across the world are still at a nascent period in creating a Regulatory framework for vaccines at a national level in their own countries. As regulatory compliance for all vaccines requires some special sets of hands-on functional experience and Regulatory expertise knowledge, organizations may find it challenging to navigate through the global Regulatory framework for Vaccines.
Title : A universal AI design framework and brokerage platform for democratised manufacturing of mRNA therapeutics
Duccio Medini, BioForge, United States
Title : Personalized and Precision Medicine (PPM) via biodesign-driven translational applications and upgraded business modeling to secure the human biosafety: The next-step vaccinomics of the future
Sergey V Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Development of VSV-vector based vaccine against H5N1 avian influenza by targeting both H5N1 hemagglutinin and matrix protein 2
Zhujun Ao, University of Manitoba, Canada
Title : A novel responsive microneedle platform for reliable drug and vaccine delivery
Huanhuan Li, Queen’s University Belfast, United Kingdom
Title : Emerging nanovaccine strategies for enhanced immune targeting and vaccine performance
Aysel Sadayli, V.Y. Axundov Scientific-Research Institute of Medical Prophylaxis, Azerbaijan
Title : The promise of nanotechnology in Personalized & Precision Medicine: Nano-driven precision vaccinomics of the future
Sergey V Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Reaching zero-dose children through adaptive immunization strategies in security-compromised areas of Zamfara State, Nigeria
Attahir Abubakar, Ahmadu Bello University, Nigeria
Title : Comparative efficacy of different H9N2 avian influenza virus inactivated vaccines using some commercially available adjuvants for superior control in broilers
Ayman H M El Deeb, Cairo University, Egypt
Title : Structure-based design and development of next-generation Respiratory Syncytial Virus (RSV) vaccine
Lei Chen, Yikang Biotech Suzhou Co., Ltd, China
Title : Unmasking urban immunization inequities: A cross-sectional LQAS analysis of zero-dose drivers in slum and non-slum settings of Uttar Pradesh, India
Ashish Kumar Maurya, John Snow India, India